ePrints

[¹⁸F]Fluciclatide PET as a biomarker of response to combination therapy of pazopanib and paclitaxel in platinum-resistant/refractory ovarian cancer

Lookup NU author(s): Dr Jingky Lozano-KuehneORCiD

Downloads

• Published version [.pdf]

Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).

Publication metadata

Author(s): Sharma R, Valls PO, Inglese M, Dubash S, Chen M, Gabra H, Montes A, Challapalli A, Arshad M, Tharakan G, Chambers E, Cole T, Lozano-Kuehne JP, Barwick TD, Aboagye EO

Publication type: Article

Publication status: Published

Journal: European Journal of Nuclear Medicine and Molecular Imaging

Year: 2020

Volume: 47

Pages: 1239–1251

Print publication date: 01/05/2020

Online publication date: 21/11/2019

Acceptance date: 11/09/2019

Date deposited: 27/01/2023

ISSN (print): 1619-7070

ISSN (electronic): 1619-7089

Publisher: Springer

URL: https://doi.org/10.1007/s00259-019-04532-z

DOI: 10.1007/s00259-019-04532-z

Altmetrics

Funding

Share